A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal Explants
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the feasibility of a novel method to assess
antiretroviral efficacy for protection against HIV-1 infection in vaginal and cervical tissue
biopsies.